These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6779333)

  • 1. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat.
    de Boer T; Bartels K; Metselaar HJ; Bruinvels J
    Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual role for GABA in quasi-morphine abstinence behavior induced by di-n-propylacetate involving both initiation and termination.
    Van der Laan JW; Bruinvels J
    Psychopharmacology (Berl); 1981; 74(2):143-8. PubMed ID: 6791219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment.
    van der Laan JW
    Life Sci; 1983; 33 Suppl 1():389-92. PubMed ID: 6420629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: involvement of amygdaloid and thalamic structures.
    van der Laan JW; Bruinvels J
    Brain Res; 1981 Dec; 229(1):133-46. PubMed ID: 6272932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of GABA-ergic substances on the analgesic effect of morphine in rats].
    Ostrovskaia RU; Bulaev VM
    Biull Eksp Biol Med; 1979 Jul; 88(7):35-7. PubMed ID: 380685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior.
    van der Laan JW; Jacobs AW; Bruinvels J
    Pharmacol Biochem Behav; 1980 Dec; 13(6):843-9. PubMed ID: 6782587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of GABA in morphine abstinence in rats.
    Kruszewska A
    Drug Alcohol Depend; 1988 Feb; 21(1):37-41. PubMed ID: 3366053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline.
    de Boer T; Metselaar HJ; Bruinvels J
    Life Sci; 1977 Mar; 20(6):933-41. PubMed ID: 191711
    [No Abstract]   [Full Text] [Related]  

  • 12. GABAergic influence on the effects of elymoclavine on exploratory behaviour of rats in open field.
    Georgiev V; Getova D; Petkov V
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):423-7. PubMed ID: 6092797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1990 Apr; 34(2):139-42. PubMed ID: 2147669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA-opiates interactions in the activity of analgesics.
    Zakusov VV; Ostrovskaya RU; Bulayev VM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):61-75. PubMed ID: 6139983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tranquilizing effect of n-dipropylacetate and other GABA-ergic substances in conflict situations].
    Kharlamov AN; Raevskiĭ KS
    Biull Eksp Biol Med; 1980 Jul; 89(7):35-7. PubMed ID: 6773597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.
    Seiler N; Sarhan S
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):49-57. PubMed ID: 6472485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.